229 related articles for article (PubMed ID: 12555297)
21. Epidemiology and prognosis of synchronous colorectal cancers.
Latournerie M; Jooste V; Cottet V; Lepage C; Faivre J; Bouvier AM
Br J Surg; 2008 Dec; 95(12):1528-33. PubMed ID: 18991301
[TBL] [Abstract][Full Text] [Related]
22. Contralateral recurrence and prognostic factors in familial non-BRCA1/2-associated breast cancer.
Tilanus-Linthorst MM; Alves C; Seynaeve C; Menke-Pluymers MB; Eggermont AM; Brekelmans CT
Br J Surg; 2006 Aug; 93(8):961-8. PubMed ID: 16758466
[TBL] [Abstract][Full Text] [Related]
23. Microsatellite instability is a predictive marker for survival benefit from adjuvant chemotherapy in a population-based series of stage III colorectal carcinoma.
Elsaleh H; Iacopetta B
Clin Colorectal Cancer; 2001 Aug; 1(2):104-9. PubMed ID: 12445368
[TBL] [Abstract][Full Text] [Related]
24. Population-based study of prognostic factors in stage II colonic cancer.
Morris M; Platell C; de Boer B; McCaul K; Iacopetta B
Br J Surg; 2006 Jul; 93(7):866-71. PubMed ID: 16622901
[TBL] [Abstract][Full Text] [Related]
25. A population-based study of age-related variation in clinicopathological features, molecular. Markers and outcome from colorectal cancer.
Morris M; Platell C; Iacopetta B
Anticancer Res; 2007; 27(4C):2833-8. PubMed ID: 17695456
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of numeric aberrations of genes for thymidylate synthase, thymidine phosphorylase and dihydrofolate reductase in colorectal cancer.
Jensen SA; Vainer B; Witton CJ; Jørgensen JT; Sørensen JB
Acta Oncol; 2008; 47(6):1054-61. PubMed ID: 18607850
[TBL] [Abstract][Full Text] [Related]
27. Analysis of somatic molecular changes, clinicopathological features, family history, and germline mutations in colorectal cancer families: evidence for efficient diagnosis of HNPCC and for the existence of distinct groups of non-HNPCC families.
Johnson V; Lipton LR; Cummings C; Eftekhar Sadat AT; Izatt L; Hodgson SV; Talbot IC; Thomas HJ; Silver AJ; Tomlinson IP
J Med Genet; 2005 Oct; 42(10):756-62. PubMed ID: 15788729
[TBL] [Abstract][Full Text] [Related]
28. Metachronous colorectal cancer.
Park IJ; Yu CS; Kim HC; Jung YH; Han KR; Kim JC
Colorectal Dis; 2006 May; 8(4):323-7. PubMed ID: 16630238
[TBL] [Abstract][Full Text] [Related]
29. Two subtypes of mucinous adenocarcinoma of the colorectum: clinicopathological and genetic features.
Leopoldo S; Lorena B; Cinzia A; Gabriella DC; Angela Luciana B; Renato C; Antonio M; Carlo S; Cristina P; Stefano C; Maurizio T; Luigi R; Cesare B
Ann Surg Oncol; 2008 May; 15(5):1429-39. PubMed ID: 18301950
[TBL] [Abstract][Full Text] [Related]
30. [Colorectal cancer in young patients: presentation, clinicopathological characteristics and outcome].
Tohmé C; Labaki M; Hajj G; Abboud B; Noun R; Sarkis R
J Med Liban; 2008; 56(4):208-14. PubMed ID: 19115594
[TBL] [Abstract][Full Text] [Related]
31. Young age influences treatment but not outcome of colon cancer.
Quah HM; Joseph R; Schrag D; Shia J; Guillem JG; Paty PB; Temple LK; Wong WD; Weiser MR
Ann Surg Oncol; 2007 Oct; 14(10):2759-65. PubMed ID: 17593332
[TBL] [Abstract][Full Text] [Related]
32. Early-onset colorectal cancer with stable microsatellite DNA and near-diploid chromosomes.
Chan TL; Curtis LC; Leung SY; Farrington SM; Ho JW; Chan AS; Lam PW; Tse CW; Dunlop MG; Wyllie AH; Yuen ST
Oncogene; 2001 Aug; 20(35):4871-6. PubMed ID: 11521198
[TBL] [Abstract][Full Text] [Related]
33. Mutations in the p53 and Ki-ras genes, microsatellite instability and site of tumor origin in colorectal cancer.
Catalano T; Curia MC; Aceto G; Verginelli F; Cascinu S; Cama A; Mariani-Costantini R; Teti D; Battista P
Oncol Rep; 2005 Sep; 14(3):625-31. PubMed ID: 16077965
[TBL] [Abstract][Full Text] [Related]
34. Colorectal cancer in patients under forty: presentation and outcome.
Parramore JB; Wei JP; Yeh KA
Am Surg; 1998 Jun; 64(6):563-7; discussion 567-8. PubMed ID: 9619179
[TBL] [Abstract][Full Text] [Related]
35. TP53 mutation and microsatellite instability status for the prediction of survival in adjuvant-treated colon cancer patients.
Watanabe T; Kanazawa T; Kazama Y; Tanaka J; Tanaka T; Ishihara S; Nagawa H
J Clin Oncol; 2005 Dec; 23(35):9031-2; author reply 9032-3. PubMed ID: 16339756
[No Abstract] [Full Text] [Related]
36. Randomized clinical trial of adjuvant radiotherapy and 5-fluorouracil infusion in colorectal cancer (AXIS).
James RD; Donaldson D; Gray R; Northover JM; Stenning SP; Taylor I;
Br J Surg; 2003 Oct; 90(10):1200-12. PubMed ID: 14515287
[TBL] [Abstract][Full Text] [Related]
37. Microsatellite instability and survival rate in the solid or nonsolid types of poorly differentiated colorectal adenocarcinoma.
Goi T; Hirono Y; Katayama K; Yamaguchi A
Int Surg; 2004; 89(2):100-6. PubMed ID: 15285243
[TBL] [Abstract][Full Text] [Related]
38. Colorectal cancer in patients younger than 40 years of age.
Keswani SG; Boyle MJ; Maxwell JP; Mains L; Wilks SM; Hunt JP; O'Leary JP
Am Surg; 2002 Oct; 68(10):871-6. PubMed ID: 12412713
[TBL] [Abstract][Full Text] [Related]
39. Clinical value of mitochondrial mutations in colorectal cancer.
Lièvre A; Chapusot C; Bouvier AM; Zinzindohoué F; Piard F; Roignot P; Arnould L; Beaune P; Faivre J; Laurent-Puig P
J Clin Oncol; 2005 May; 23(15):3517-25. PubMed ID: 15908662
[TBL] [Abstract][Full Text] [Related]
40. Sporadic colorectal carcinomas with low-level microsatellite instability in Korea: do they form a distinct subgroup with distinguished clinicopathological features?
Kim YH; Min BH; Choi HK; Kim SJ; Kim KM; Kim JY; Chang DK; Son HJ; Rhee PL; Kim JJ; Rhee JC; Chun HK
J Surg Oncol; 2009 May; 99(6):351-5. PubMed ID: 19204939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
